Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CD31 (PECAM-1) is a highly abundant cell surface glycoprotein expressed on hemopoietic and endothelial cells where it functions as a homophilic adhesion and signaling receptor. Since dimerization and appropriate glycosylation are important features in the regulation of cell surface interactions and signal transduction, we studied the pattern of glycosylation as well as the ability of CD31 to undergo dimerization, both in solution and when expressed on cell membranes. CD31 is heavily glycosylated, with an approximate carbohydrate content of 21%. Nineteen neutral and thirteen sialylated glycans were identified. Ultracentrifugation analysis showed that soluble recombinant CD31 exists in equilibrium between a monomer and a dimer with an approximate dissociation constant of 12.5 microM. Chemical cross-linking studies of both soluble and membrane-expressed CD31 confirmed that CD31 exists as a dimer. These studies suggest that, like E-cadherin, PECAM-dimerization is likely to play a role in CD31 adhesion and signaling.

Original publication




Journal article


Biochem biophys res commun

Publication Date





283 - 291


Animals, Base Sequence, Carbohydrate Sequence, Cell Adhesion, Cell Membrane, Cross-Linking Reagents, DNA Primers, Dimerization, Glycosylation, Humans, In Vitro Techniques, Molecular Sequence Data, Molecular Weight, Platelet Endothelial Cell Adhesion Molecule-1, Polysaccharides, Protein Conformation, Recombinant Proteins, Signal Transduction, Solutions, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization